These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16513880)

  • 1. No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome.
    Glaser B; Debbane M; Hinard C; Morris MA; Dahoun SP; Antonarakis SE; Eliez S
    Am J Psychiatry; 2006 Mar; 163(3):537-9. PubMed ID: 16513880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome.
    Bearden CE; Jawad AF; Lynch DR; Sokol S; Kanes SJ; McDonald-McGinn DM; Saitta SC; Harris SE; Moss E; Wang PP; Zackai E; Emanuel BS; Simon TJ
    Am J Psychiatry; 2004 Sep; 161(9):1700-2. PubMed ID: 15337663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
    Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
    J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a functional COMT polymorphism on brain anatomy and cognitive function in adults with velo-cardio-facial syndrome.
    van Amelsvoort T; Zinkstok J; Figee M; Daly E; Morris R; Owen MJ; Murphy KC; De Haan L; Linszen DH; Glaser B; Murphy DG
    Psychol Med; 2008 Jan; 38(1):89-100. PubMed ID: 17493297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
    Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
    Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome.
    Shashi V; Howard TD; Keshavan MS; Kaczorowski J; Berry MN; Schoch K; Spence EJ; Kwapil TR
    Psychiatry Res; 2010 Jul; 178(2):433-6. PubMed ID: 20488547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome.
    Shashi V; Keshavan MS; Howard TD; Berry MN; Basehore MJ; Lewandowski E; Kwapil TR
    Clin Genet; 2006 Mar; 69(3):234-8. PubMed ID: 16542388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome.
    Baker K; Baldeweg T; Sivagnanasundaram S; Scambler P; Skuse D
    Biol Psychiatry; 2005 Jul; 58(1):23-31. PubMed ID: 15935994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IQ and hemizygosity for the Val
    Franconi CP; McDonald-McGinn D; Zackai EH; McNamara MA; Salmons H; Moss E; Gur RE; Devoto M; Emanuel BS
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1112-1115. PubMed ID: 27619075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion Syndrome.
    Bearden CE; Jawad AF; Lynch DR; Monterossso JR; Sokol S; McDonald-McGinn DM; Saitta SC; Harris SE; Moss E; Wang PP; Zackai E; Emanuel BS; Simon TJ
    Child Neuropsychol; 2005 Feb; 11(1):109-17. PubMed ID: 15846854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS.
    Michaelovsky E; Gothelf D; Korostishevsky M; Frisch A; Burg M; Carmel M; Steinberg T; Inbar D; Apter A; Weizman A
    Int J Neuropsychopharmacol; 2008 May; 11(3):351-63. PubMed ID: 17949513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome.
    Takarae Y; Schmidt L; Tassone F; Simon TJ
    Cogn Affect Behav Neurosci; 2009 Mar; 9(1):83-90. PubMed ID: 19246329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.
    Zarchi O; Carmel M; Avni C; Attias J; Frisch A; Michaelovsky E; Patya M; Green T; Weinberger R; Weizman A; Gothelf D
    J Psychiatr Res; 2013 Nov; 47(11):1623-9. PubMed ID: 23910792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.
    Gothelf D; Eliez S; Thompson T; Hinard C; Penniman L; Feinstein C; Kwon H; Jin S; Jo B; Antonarakis SE; Morris MA; Reiss AL
    Nat Neurosci; 2005 Nov; 8(11):1500-2. PubMed ID: 16234808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive functions and memory abilities in children with 22q11.2 deletion syndrome.
    Campbell LE; Azuma R; Ambery F; Stevens A; Smith A; Morris RG; Murphy DG; Murphy KC
    Aust N Z J Psychiatry; 2010 Apr; 44(4):364-71. PubMed ID: 20307169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gender-moderated effect of a functional COMT polymorphism on prefrontal brain morphology and function in velo-cardio-facial syndrome (22q11.2 deletion syndrome).
    Kates WR; Antshel KM; Abdulsabur N; Colgan D; Funke B; Fremont W; Higgins AM; Kucherlapati R; Shprintzen RJ
    Am J Med Genet B Neuropsychiatr Genet; 2006 Apr; 141B(3):274-80. PubMed ID: 16511839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults.
    de Frias CM; Annerbrink K; Westberg L; Eriksson E; Adolfsson R; Nilsson LG
    J Cogn Neurosci; 2005 Jul; 17(7):1018-25. PubMed ID: 16102234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
    Bosia M; Bechi M; Marino E; Anselmetti S; Poletti S; Cocchi F; Smeraldi E; Cavallaro R
    Neurosci Lett; 2007 May; 417(3):271-4. PubMed ID: 17383818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.